A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
The purpose of this study is to obtain surgical technique data for use in physician education
 and training and to collect early clinical outcomes data for future publication.
A multi-center study conducted under a common implant and follow-up protocol. The study will
 collect pre-operative urologic testing, medical history and subject quality of life
 (Incontinence Quality of Life Questionnaire). Intra-operative procedural data will be
 collected.

 Pad weight and incontinence severity rating (using the International Consultation on
 Incontinence Questionnaire (ICIQ)) will be used to characterize continence status.

 Post-operative complications, urologic testing, and subject quality of life will be collected
 at six weeks and three, six, 12, and 24 months.
Inclusion Criteria:

 1. The subject has agreed to be implanted with the AMS Male Transobturator Sling System.

 2. The subject is willing and able to give valid informed consent.

 3. The subject is > 40 years of age.

 4. The subject has confirmed stress urinary incontinence for at least 6 months and uses
 no more than 8 pads per day for incontinence management.

 5. The subject has any of the following: an observable degree of incontinence during
 stress related activities, more than one pad is used in a 24 hour period, has more
 than two episodes of incontinence per day.

 6. Internal sphincter contractility confirmed by endoscopic view.

 7. The subject's primary etiology is TUR, TURP, radical prostatectomy, open
 prostatectomy, or suprapubic prostatectomy

 8. Pre-existing urological conditions, other than incontinence have been treated and are
 under control.

 9. The subject is willing and able to return for follow-up evaluations and questionnaire
 completion according to the study protocol.

 10. The subject is a good surgical candidate.

 Exclusion Criteria:

 1. The subject has a neurogenic bladder condition that is not treatable or controllable
 by pharmacological or alternative methods.

 2. The subject has an atonic bladder.

 3. The subject has a post-void residual > 75 cc.

 4. The subject has detrusor-external sphincter dyssynergia.

 5. The subject has a urinary tract infection (UTI).

 6. The subject was treated with pelvic radiation within the last 6 months.

 7. The subject currently has an inflatable penile prosthesis.

 8. The subject self-catheterizes.

 9. The subject has symptomatic or unstable bladder neck stricture disease.

 10. The subject has a history of urethral strictures that may require repetitive
 instrumentation.

 11. The subject has previously had a urethral Sling System, an AMS Sphincter 800™, or any
 implanted device for the treatment of urinary incontinence (not including bulking
 agents).

 12. The subject has a history of connective tissue or autoimmune conditions.

 13. The subject has a compromised immune system.

 14. The subject has renal insufficiency, and upper and/or lower urinary tract relative
 obstruction.

 15. The subject's reading level is judged inadequate for reading and understanding the
 quality of life questionnaires and other study materials.